These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2708138)

  • 1. Biological properties of ER 42859, a novel erythromycin derivative.
    Wilson JM; Hannan PC; Shillingford C; Knowles DJ
    J Antibiot (Tokyo); 1989 Mar; 42(3):454-62. PubMed ID: 2708138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
    Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus].
    Rolin O; Bouanchaud DH
    Pathol Biol (Paris); 1989 May; 37(5):375-7. PubMed ID: 2780094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of roxithromycin: a laboratory evaluation.
    Chantot JF; Bryskier A; Gasc JC
    J Antibiot (Tokyo); 1986 May; 39(5):660-8. PubMed ID: 3733515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of roxithromycin against respiratory and skin pathogens.
    Pechére JC; Auckenthaler R
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():1-5. PubMed ID: 3501424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro antimycoplasmal activity of flurithromycin.
    Furneri PM; Bisignano G; Cerniglia G; Tempera G; Nicoletti G
    J Antimicrob Chemother; 1995 Jan; 35(1):161-5. PubMed ID: 7768764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro potencies of nine new macrolides.
    Fernandes PB; Hardy DJ
    Drugs Exp Clin Res; 1988; 14(7):445-51. PubMed ID: 3240705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
    Kohno S; Koga H; Yamaguchi K; Masaki M; Inoue Y; Dotsu Y; Masuyama Y; Hayashi T; Hirota M; Saito A
    J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro evaluation of the antimicrobial activity of flurithromycin by means of the MS-2 Abbott Research System.
    Periti P; Nicoletti P; Novelli A
    Chemioterapia; 1985 Apr; 4(2):156-60. PubMed ID: 3924422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of macrolides against organisms responsible for respiratory infection with emphasis on Mycoplasma and Legionella.
    Hara K; Suyama N; Yamaguchi K; Kohno S; Saito A
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():75-80. PubMed ID: 3429389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae.
    Goldstein FW; Emirian MF; Coutrot A; Acar JF
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():25-8. PubMed ID: 2154434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of flurithromycin against some genital pathogens.
    Furneri PM; Tempera G; Lepore AM; Bonfanti C; Nicoletti G
    Drugs Exp Clin Res; 1991; 17(3):175-80. PubMed ID: 1914844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of josamycin, spiramycin, and erythromycin against Rickettsia rickettsii and R. conorii.
    Raoult D; Roussellier P; Tamalet J
    Antimicrob Agents Chemother; 1988 Feb; 32(2):255-6. PubMed ID: 3129987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of clindamycin, erythromycin and spiramycin against Staphylococcus aureus in the rat croton oil pouch model.
    Davey PG; Jacobus NV; Tally FP
    J Antimicrob Chemother; 1987 Nov; 20(5):705-12. PubMed ID: 3429372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection and the antibiotic susceptibility analysis of mycoplasma and chlamydia in urogenital tract infections of 327 cases patients with tubal infertility].
    Zhou Y; Xu XL; Wang CP; Zhou M; Zeng XH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):201-4. PubMed ID: 21977592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activities of four macrolides: josamycin, erythromycin, spiramycin and roxithromycin, against 424 anaerobic bacteria.
    Derriennic M; Dubreuil L; Reynaud AE; Courtieu AL
    Chemioterapia; 1987 Jun; 6(2 Suppl):159-60. PubMed ID: 3509376
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioactivity of flurithromycin and other macrolides against intracellular susceptible staphylococci.
    Fietta A; Boeri P; Colombo ML; Merlini C; Gialdroni Grassi G
    Chemotherapy; 1993; 39(1):48-54. PubMed ID: 8444060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antipneumococcal activity of erythromycin and spiramycin in 2 experimental models in mice].
    Rolin O; Bouanchaud DH
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):742-5. PubMed ID: 3309807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
    Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.